With generics poised to make semaglutide widely accessible in India, this medication has the potential to transform obesity ...
In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...
The weighing scale has long been seen as the final word on health. A number goes up or down, and people react. But doctors are now asking a simple question: what if that number is not telling the full ...
Health and Me on MSN
Diabetes diet plan: South Indian breads that are better than roti
For a diabetes patient, diet is the most important form of medication. And in India, where roti is one of the most important ...
Semaglutide is used for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an add-on to the treatment process that also utiilises diet and exercise.
From a diabetes drug to a global weight-loss phenomenon, semaglutide has reshaped modern medicine. As patents expire, cheaper ...
Kidney stone risks exponentially go up because of a few lifestyle habits and practices. Know from a urologist how to curb the risks. | Health ...
On Friday (13 March), the patent on semaglutide — the molecule behind Danish drugmaker Novo Nordisk’s blockbuster weight-loss drugs Wegovy and Ozempic — expires in the country ...
The partnership focuses on enhancing patient reach for cutting-edge diabetes care and chronic weight management solutions.
Lupin and Zydus partner to co-market semaglutide in India, entering a Rs 1,200 crore market with over 20 competitors and rapidly commoditising pricing dynamics.
Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results